Regulus Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	74.79	176.13	115.02	101.4	144.43	26.76	Upgrade
Short-Term Investments	-	20.06	60.31	70.37	50.22	-	Upgrade
Trading Asset Securities	160.05	63.3	65.51	70.31	60.16	-	Upgrade
Cash & Short-Term Investments	234.84	259.49	240.84	242.08	254.81	26.76	Upgrade
Cash Growth	46.27%	7.75%	-0.51%	-5.00%	852.03%	-26.27%	Upgrade
Accounts Receivable	233.79	254.23	303.94	353	241.35	186.01	Upgrade
Other Receivables	5.99	10.66	7.4	8.03	6.76	10.24	Upgrade
Receivables	239.78	264.89	311.34	361.03	248.1	196.25	Upgrade
Inventory	76.55	81.97	71.55	62.68	42.01	41.06	Upgrade
Other Current Assets	15.83	6.57	0.84	0.84	1.05	2.05	Upgrade
Total Current Assets	566.99	612.93	624.57	666.63	545.97	266.13	Upgrade
Property, Plant & Equipment	116.42	110.12	88.55	86.95	74.07	88.44	Upgrade
Long-Term Investments	4.08	4.08	4.08	4.08	4.08	4.08	Upgrade
Other Intangible Assets	27.2	28.08	31.61	17.33	19.48	21.62	Upgrade
Long-Term Accounts Receivable	-	11.06	8.63	7.12	4.94	-	Upgrade
Long-Term Deferred Tax Assets	6.41	6.08	5.68	5.16	3.21	2.59	Upgrade
Long-Term Deferred Charges	-	-	-	8.87	2.26	-	Upgrade
Other Long-Term Assets	22.6	12.99	13.51	16.49	20.38	7.55	Upgrade
Total Assets	743.7	785.34	776.64	812.62	674.38	390.4	Upgrade
Accounts Payable	113.41	150.71	176.42	202.77	127.44	76.13	Upgrade
Accrued Expenses	2.25	7.75	12.27	18.93	9.79	8.12	Upgrade
Short-Term Debt	-	-	-	5	-	10.01	Upgrade
Current Portion of Long-Term Debt	8.01	9.01	-	-	-	-	Upgrade
Current Income Taxes Payable	0.41	0.01	-	11.58	6.36	4.27	Upgrade
Current Unearned Revenue	6.47	3.8	3.48	0.65	0.61	3.25	Upgrade
Other Current Liabilities	5.37	8.54	3.27	1.45	1.14	1.7	Upgrade
Total Current Liabilities	135.92	179.83	195.43	240.38	145.36	103.48	Upgrade
Long-Term Unearned Revenue	8.88	8.88	5.04	3.04	2.48	5.4	Upgrade
Long-Term Deferred Tax Liabilities	-	-	-	0.07	0.02	-	Upgrade
Total Liabilities	144.8	188.71	200.47	243.48	147.86	108.88	Upgrade
Common Stock	87.62	87.62	87.36	87.1	86.75	65.06	Upgrade
Additional Paid-In Capital	256.08	256.08	253.47	249.28	240.74	74.72	Upgrade
Retained Earnings	252.87	250.61	233.08	230.46	196.76	139.5	Upgrade
Total Common Equity	596.58	594.32	573.91	566.84	524.25	279.29	Upgrade
Minority Interest	2.32	2.31	2.25	2.3	2.27	2.23	Upgrade
Shareholders' Equity	598.9	596.63	576.17	569.14	526.52	281.51	Upgrade
Total Liabilities & Equity	743.7	785.34	776.64	812.62	674.38	390.4	Upgrade
Total Debt	8.01	9.01	-	5	-	10.01	Upgrade
Net Cash (Debt)	226.83	250.49	240.84	237.08	254.81	16.75	Upgrade
Net Cash Growth	50.67%	4.00%	1.59%	-6.96%	1420.92%	-53.85%	Upgrade
Net Cash Per Share	2.59	2.86	2.76	2.74	3.34	0.26	Upgrade
Filing Date Shares Outstanding	87.62	87.62	87.36	87.1	86.75	65.06	Upgrade
Total Common Shares Outstanding	87.62	87.62	87.36	87.1	86.75	65.06	Upgrade
Working Capital	431.07	433.1	429.14	426.25	400.61	162.64	Upgrade
Book Value Per Share	6.81	6.78	6.57	6.51	6.04	4.29	Upgrade
Tangible Book Value	569.38	566.24	542.3	549.51	504.78	257.67	Upgrade
Tangible Book Value Per Share	6.50	6.46	6.21	6.31	5.82	3.96	Upgrade
Buildings	-	103.99	103.91	100.54	84.22	101.34	Upgrade
Machinery	-	27.66	27.17	24.48	22.93	20.72	Upgrade
Construction In Progress	-	27.97	1.23	-	0.52	-	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.